Bumper Offer - Urjas oil Just @ Rs. 1
Nucipro 0.3% Eye Drops is a commercial drug that is prescribed in the form of Drops. It is typically used for the treatment of Urinary Tract Infection, Bacterial Infections. The alternative uses of Nucipro 0.3% Eye Drops have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Nucipro 0.3% Eye Drops. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Nucipro 0.3% Eye Drops as well, which are listed below. Normally, these side effects of Nucipro 0.3% Eye Drops are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Nucipro 0.3% Eye Drops's effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Nucipro 0.3% Eye Drops's effects on the liver, heart and kidney, if any, have been listed below.
Nucipro 0.3% Eye Drops is contraindicated in people with pre-existing medical conditions like Arrhythmia, Heart Disease, Myasthenia Gravis (MG) as it can result in adverse effects. Other conditions have been mentioned below in the Nucipro 0.3% Eye Drops contraindications section.
Additionally, Nucipro 0.3% Eye Drops may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Nucipro 0.3% Eye Drops is considered not safe while driving, and is not addictive.
Nucipro 0.3% Eye Drops is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
Based on research, the following side effects have been observed when Nucipro 0.3% Eye Drops is used -
Severe
Moderate
Mild
Is the use of Nucipro 0.3% Eye Drops safe for pregnant women?
Nucipro 0.3% Eye Drops may have some side effects during pregnancy. Pregnant women should discontinue the use of Nucipro 0.3% Eye Drops, and talk to their doctor, if they notice any discomfort.
Is the use of Nucipro 0.3% Eye Drops safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Nucipro 0.3% Eye Drops. Immediately discontinue Nucipro 0.3% Eye Drops if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Nucipro 0.3% Eye Drops on the Kidneys?
Nucipro 0.3% Eye Drops rarely affects the kidneys.
What is the effect of Nucipro 0.3% Eye Drops on the Liver?
Nucipro 0.3% Eye Drops has very mild side effects on the liver.
What is the effect of Nucipro 0.3% Eye Drops on the Heart?
Nucipro 0.3% Eye Drops may have mild side effects on the heart. Most people will never see any effect on the heart.
Nucipro 0.3% Eye Drops should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Nucipro 0.3% Eye Drops unless your doctor advises you to do so -
Is this Nucipro 0.3% Eye Drops habit forming or addictive?
Yes, you can get addicted to Nucipro 0.3% Eye Drops. It is essential that you take [medicine] only after doctor's recommendation.
Is it safe to drive or operate heavy machinery when consuming?
After taking Nucipro 0.3% Eye Drops you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Nucipro 0.3% Eye Drops only as per medical advice.
Is it able to treat mental disorders?
No, Nucipro 0.3% Eye Drops cannot treat any kind of mental disorder.
Interaction between Food and Nucipro 0.3% Eye Drops
Taking Nucipro 0.3% Eye Drops with food can show serious side effects. Consult the doctor to avoid this.
Interaction between Alcohol and Nucipro 0.3% Eye Drops
Taking alcohol with Nucipro 0.3% Eye Drops can be dangerous.
Yes, Nucipro 0.3% Eye Drops can be taken with dextromethorphan. There are no known interactions between them. However, if you are experiencing any side effects after taking these two medicines to inform your doctor.
Nucipro 0.3% Eye Drops is a brand name for ciprofloxacin. It is a prescription drug that belongs to the class of medication called fluoroquinolones. It is a broad spectrum antibiotic, used for treating bacterial infections, such as bronchitis, pneumonia, urinary, respiratory, skin, gastrointestinal, anthrax, and bone infections.
It is recommended to avoid taking Nucipro 0.3% Eye Drops with azithromycin because it can cause problems. However, if your doctor has prescribed it to you take it as per his/her advice. In case you are experiencing breathing difficulties, palpitations and pain in the chest please inform your doctor immediately.
Nucipro 0.3% Eye Drops is not recommended as the first-line of a drug for treating a sinus infection. However, if there are no other alternatives available then you can take it. Keep your doctor informed.
Yes, Nucipro 0.3% Eye Drops can be taken with omeprazole, no harmful interaction have been observed between them. However, please consult your doctor before taking these two medicines at the same time.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cipro® (ciprofloxacin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 710-713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584